CpG dinucleotide methylation of the SPDEF gene as a blood-based epigenetic biomarker for prostate cancer diagnosis
Hypomethylation of a specific CpG dinucleotide in the SPDEF promoter may serve as a promising noninvasive blood-based biomarker for the early detection and clinical stratification of prostate cancer.
Authors
- Mohammad Vahid Ahmadianpour (ORCID: https://orcid.org/0000-0002-4574-2927)
- Ahmad Aleyasin (ORCID: https://orcid.org/0000-0002-2526-4884)
Institutions
- National Institute of Genetic Engineering and Biotechnology (IR)
Publication Details
- Journal
- BMC Urology
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1186/s12894-025-01824-5
- Citations
- 1
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- National Institute for Genetic Engineering and Biotechnology
- Institute of Genetics